Wickham; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wickham; Thomas.The latest application filed is for "functionalized erythroid cells".

Company Profile

6.14.25

Wickham; Thomas - Groton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Functionalized Erythroid Cells App 20210290682 - Wickham; Thomas ; et al.	2021-09-23
Bi-Specific Fusion Proteins App 20210214463 - Nielsen; Ulrik ; et al.	2021-07-15
Bi-specific fusion proteins Grant 10,988,547 - Nielsen , et al. April 27, 2	2021-04-27
Bi-Specific Fusion Proteins App 20210040233 - Nielsen; Ulrik Bjerl ; et al.	2021-02-11
Bi-specific fusion proteins Grant 10,858,450 - Nielsen , et al. December 8, 2	2020-12-08
Bi-Specific Fusion Proteins App 20200048368 - Nielsen; Ulrik ; et al.	2020-02-13
Bi-specific fusion proteins Grant 10,407,512 - Nielsen , et al. Sept	2019-09-10
Bi-Specific Fusion Proteins App 20180237540 - Nielsen; Ulrik Bjerl ; et al.	2018-08-23
Bi-specific fusion proteins Grant 9,982,060 - Nielsen , et al. May 29, 2	2018-05-29
Compositions and methods for non-invasive imaging Grant 9,968,694 - Drummond , et al. May 15, 2	2018-05-15
Combination therapy for treating HER2-positive cancers Grant 9,913,901 - Moyo , et al. March 13, 2	2018-03-13
Bi-Specific Fusion Proteins App 20170335015 - Nielsen; Ulrik ; et al.	2017-11-23
Combination Therapies For Treating Her2-positive Cancers That Are Resistant To Her2-targeted Therapies App 20170258903 - Espelin; Christopher W. ; et al.	2017-09-14
Methods And Compositions For Improving Outcomes Of Liposomal Chemotherapy App 20170231911 - GERETTI; Elena ; et al.	2017-08-17
Method of treating myocardial infarction by administering a bi-specific fusion protein Grant 9,718,892 - Nielsen , et al. August 1, 2	2017-08-01
Dosage And Administration For Preventing Cardiotoxicity In Treatment With Erbb2-targeted Immunoliposomes Comprising Anthracycline Chemotherapeutic Agents App 20170189335 - Reynolds; Joseph G. ; et al.	2017-07-06
Compositions and Methods for Non-Invasive Imaging App 20170112950 - DRUMMOND; DARYL C. ; et al.	2017-04-27
Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents Grant 9,610,249 - Reynolds , et al. April 4, 2	2017-04-04
Combination Therapies for Treating Her2-Positive Cancers that are Resistant to Her2-Targeted Therapies App 20170080087 - ESPELIN; CHRISTOPHER ; et al.	2017-03-23
Combination Therapies For Treating Her2-positive Cancers App 20170022290 - MOYO; VICTOR ; et al.	2017-01-26
Compositions and methods for non-invasive imaging Grant 9,511,155 - Drummond , et al. December 6, 2	2016-12-06
Liposomes Useful For Non-invasive Imaging And Drug Delivery App 20160303264 - HENDRIKS; BART S. ; et al.	2016-10-20
Combination Therapy For Treating Her2-positive Cancers App 20160250328 - Moyo; Victor ; et al.	2016-09-01
Methods And Compositions For Improving Outcomes Of Liposomal Chemotherapy App 20160184227 - GERETTI; ELENA ; et al.	2016-06-30
Bi-Specific Fusion Proteins App 20160168269 - Nielsen; Ulrik ; et al.	2016-06-16
Methods And Compositions For Improving Outcomes Of Liposomal Chemotherapy App 20160067182 - GERETTI; ELENA ; et al.	2016-03-10
Combination Therapies For Treating Her2-positive Cancers That Are Resistant To Her2-targeted Therapies App 20160045596 - Geretti; Elena ; et al.	2016-02-18
Dosage And Administration For Preventing Cardiotoxicity In Treatment With Erbb2-targeted Immunoliposomes Comprising Anthracycline Chemotherapeutic Agents App 20160038416 - REYNOLDS; JOSEPH G. ; et al.	2016-02-11
Dosage And Administration For Preventing Cardiotoxicity In Treatment With Erbb2-targeted Immunoliposomes Comprising Anthracycline Chemotherapeutic Agents App 20160038417 - REYNOLDS; JOSEPH G. ; et al.	2016-02-11
Bi-specific fusion proteins Grant 9,238,080 - Nielsen , et al. January 19, 2	2016-01-19
Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents Grant 9,226,966 - Reynolds , et al. January 5, 2	2016-01-05
Compositions And Methods For Non-invasive Imaging App 20150093328 - Drummond; Daryl C. ; et al.	2015-04-02
Bi-specific fusion proteins for tissue repair Grant 8,691,771 - Nielsen , et al. April 8, 2	2014-04-08
Dosage And Administration For Preventing Cardiotoxicity In Treatment With Erbb2-targeted Immunoliposomes Comprising Anthracyclin Chemotherapeutic Agents App 20140023698 - Reynolds; Joseph G. ; et al.	2014-01-23
Bi-specific fusion proteins App 20110293579 - Nielsen; Ulrik ; et al.	2011-12-01
Bi-specific Fusion Proteins App 20110286976 - NIELSEN; ULRIK ; et al.	2011-11-24
Cancer Treatments with Radiation and Immunocytokines App 20100330029 - Wickham; Thomas ; et al.	2010-12-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.